telemundo51.com/noticias/local… Honored to be investigator using Tisotumab Vedotin Pfizer Inc. Genmab that received FDA Oncology U.S. FDA approval for women with cervical cancer. Grateful to Telemundo for helping to raise cervical cancer awareness 名生 千夏 IJGC The GOG Foundation Inc. Mount Sinai Medical Center

WATCH: Sarah Sammons, MD, discusses some of the problems seen with brain metastasis in HER2-positive metastatic breast cancer. #bcsm | Dr Sarah Sammons Dana-Farber’s Breast Oncology Center Dana-Farber targetedonc.com/view/challenge…

Systematic Reviews - An Introduction - 4 mistakes people make - How to Search

The USPSTF latest guidelines on screening for breast cancer recommends that all women undergo routine screening every other year beginning at age 40. View a comprehensive collection of resources on these guidelines to help inform your clinical practice: ja.ma/3YJbxXK

Our latest selected abstracts presented at SNO2024 - Vivek Podder, MBBS Manmeet Ahluwalia, MD, MBA, FASCO oncodaily.com/insight/192403 #Cancer #OncoDaily #Oncology #SNO2024 #MedEd #MedX #MedNews #Medicine

🤔How safe are #ICIs for brain metastases? 💡Our new Cancers review explores irAEs, neurotoxicity, and combination strategies with SRS/chemo for better patient outcomes. Read more▶️mdpi.com/2072-6694/16/2… By Vivek Podder et al. Vivek Podder, MBBS Manmeet Ahluwalia, MD, MBA, FASCO Baptist Health

The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial - Annals of Oncology annalsofoncology.org/article/S0923-…

Fantastic ER+ #bcsm summary and algorithm by Dr. Danso at year in review. First line CDK 2nd line profile driven ADC/chemo once endo-R! SABCS #SABCS24 OncoAlert

🧬🩸Exciting update! LB-RECIST introduces a new era for evaluating tumor response using liquid biopsy (ctDNA), addressing limits of imaging in solid tumors. A step toward precision oncology! #LiquidBiopsy #Oncology #PrecisionMedicine #ESMO OncoAlert The Journal of Liquid Biopsy Christian Rolfo

How do we make sense of two “negative” trials in NEJM and a “positive” meta-analysis of the two trials in NEJM Evidence? Emil Hodzic-Santor and Michael Fralick share some insights in this editorial: eviden.cc/3OYutgJ

Endocrine Treatments for Patients Diagnosed with Endometrial Cancer in 2025 - Vivek Podder, MBBS oncodaily.com/drugs/vivek-po… #Health #Medicine #Cancer #OncoDaily #Oncology #EndometrialCancer #EndocrineTherapy #MedX

Excited to share our new IJGC editorial: “Precision oncology in endometrial cancer: closing the gap between potential and practice” w/ Brian Slomovitz, MD, MS, FACOG We explore genomics, racial disparities, immunotherapy, & access barriers. Read here: sciencedirect.com/science/articl…

#Editorial The challenge is no longer whether precision oncology can improve outcomes in #endometrialcancer but how rapidly and effectively these advancements can be integrated into standard clinical practice. 📌 bit.ly/4363lDa Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj

pubmed.ncbi.nlm.nih.gov/40253116/ Does metformin work to cure #endometrialcancer? Vivek Podder, MBBS Mount Sinai Medical Center NRG Oncology The GOG Foundation Inc. Mount Sinai Medical Center

pubmed.ncbi.nlm.nih.gov/40233470/ Using precision molecular classifications to treat endometrial cancer! So many new options for our patients. Vivek Podder, MBBS Mount Sinai Medical Center

Honored to be a co-investigator on this practice changing trial. The GOG Foundation Inc. Mount Sinai Medical Center

The man in seat 11A survived, but why don’t our patients? kevinmd.com/2025/06/the-ma… via Kevin Pho, M.D.

The man in seat 11A survived, but why don’t our patients? dlvr.it/TLRd9l #Physician #PrimaryCare via Kevin Pho, M.D.

We need better treatments for our patients with advanced/metastatic cervix cancer!!! Open and accruing Mount Sinai Medical Center clinicaltrials.gov/study/NCT06459…

NEW: FDA releases draft guidance on overall survival assessment in oncology trials, with an emphasis on analyzing overall survival as a pre-specified safety endpoint. fda.gov/regulatory-inf…